Global licensing

Strategic alliances are the key drivers of growth and innovation in our increasingly globalised and networked world. We facilitate in-licensing and out-licensing partnerships that bring together companies with complementary competencies to strengthen pipelines, achieve economies of scale, advance technologies, and introduce commercial products to market.

With a robust biologics portfolio of finished products as well as bulk from our strategic partners of high repute, a staged backward integration project is made viable. Many of our clients have secured long term supply contracts with the Government in countries where local manufacturing is supported by the authorities.

A typical staged backward integration model starts with finished product registration and supplies but often transitions into secondary packaging followed by local filling and QC release and eventually formulation filling and QC release. A further backward integration step of API/DS manufacturing is also possible in specific instances.

We actively seek strategic partners around the world who are interested in commercialising their vaccine and biosimilar assets in emerging markets through in-licensing opportunities. arrangements. We also offer scouting support, to generate a flow of new opportunities.

We also support international speciality pharmaceutical companies looking to advance their assets in newer markets through partnerships with local pharmaceutical companies and distributors, by providing support for regulatory approval and commercialisation of the products in each market.

Strategic Partners

We help local companies and organisations in the developing world secure long-term supply contracts of quality, affordable vaccines and biosimilars through project localisation initiatives and partnerships with established manufacturers of biotech/biological products.

Strategic Partners

We help local companies and organisations in the developing world secure long-term supply contracts of quality, affordable vaccines and biosimilars through project localisation initiatives and partnerships with established manufacturers of biotech/biological products.

Learn more about our current licensing opportunities

Looking to partner or out-license your assets? We work with many biotech and pharma companies all over the world to facilitate their in- and out-licensing efforts. Submit your assets and let us help you build a successful partnership.


Read the stories behind the science

We drafted a comprehensive master plan to indigenize vaccine manufacturing in Nigeria
We oversaw the first successful import and deployment of a vaccine from East Asia into Saudi Arabia

Vaccines are the most cost-effective health care interventions there are. A dollar spent on a childhood vaccination not only helps save a life, but greatly reduces spending on future healthcare.

Ezekiel Emanuel

Close Menu